The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses
Abstract
BACKGROUND: Although radiofrequency catheter ablation (RFA) has evolved from an experimental procedure to an important treatment option for atrial fibrillation, the relative safety and efficacy of catheter ablation relative to that of antiarrhythmic drug (AAD) therapy has not been established. METHODS AND RESULTS: Two separate systematic reviews were conducted: one on RFA and the other on AAD to provide accurate and broadly representative estimates of the clinical efficacy and safety of both therapies in the treatment of atrial fibrillation. Electronic searches were conducted in EMBASE and MEDLINE from 1990 to 2007. For the RFA review, all study designs were accepted. For the AAD review, articles were limited to prospective studies on the following drugs of interest: amiodarone, dofetilide, sotalol, flecainide, and propafenone. Data were extracted by 1 reviewer, with a second reviewer performing independent confirmation of extracted data. Sixty-three RFA and 34 AAD studies were included in the reviews. Patients enrolled in RFA studies tended to be younger (mean age, 55 versus 62 years), had longer duration of atrial fibrillation (6.0 versus 3.1 years), and had failed a greater number of prior drug trials (2.6 versus 1.7). The single-procedure success rate of ablation off AAD therapy was 57% (95% CI, 50% to 64%), the multiple procedure success rate off AAD was 71% (95% CI, 65% to 77%), and the multiple procedure success rate on AAD or with unknown AAD usage was 77% (95% CI, 73% to 81%). In comparison, the success rate for AAD therapy was 52% (95% CI, 47% to 57%). A major complication of catheter ablation occurred in 4.9% of patients. Adverse events for AAD studies, although more common (30% versus 5%), were less severe. CONCLUSIONS: Studies of RFA for treatment of atrial fibrillation report higher efficacy rates than do studies of AAD therapy and a lower rate of complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Catheter ablation of AF is effective in restoring and maintaining sinus rhythm in patients with symptomatic paroxysmal, persistent, and probably long-standing persistent AF -in general as second-line treatment after failure of or intolerance to antiarrhythmic drug therapy.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“In such patients, catheter ablation is more effective than antiarrhythmic drug therapy.185,586,713,[717][718][719][720]”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“In patients who experience symptomatic recurrences of AF despite antiarrhythmic drug therapy, all RCTs showed better sinus rhythm maintenance with catheter ablation than on antiarrhythmic drugs.586,713,727,728”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“Most patients require more than one procedure to achieve symptom control.713,726,728”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“The rhythm outcome after catheter ablation of AF is difficult to predict in individual patients.173,227,713,728”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“Sinus rhythm without severely symptomatic recurrences of AF is found in up to 70% of patients with paroxysmal AF, and around 50% in persistent AF. 713,728,735,1042”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“a meta-analysis of the available (weak) evidence suggests slightly better prevention of recurrent AF in patients treated with antiarrhythmic drugs after catheter ablation.713”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Cappato, R., Calkins, H., Chen, S.-A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.-H., Klein, G., Natale, A., Packer, D., et al. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.859116 · Cited by 2,852
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
Cook, D. J., Mulrow, C. D., & Haynes, R. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-5-199703010-00006 · Cited by 2,184
Nademanee, K., McKenzie, J. P., Kosar, E. M., Schwab, M., Sunsaneewitayakul, B., Vasavakul, T., Khunnawat, C., & Ngarmukos, T. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.054 · Cited by 2,004
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haı̈ssaguerre, M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.04.005 · Cited by 1,690
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins
Chen, S., HSIEH, M., TAI, C., Tsai, C.-F., Prakash, V. S., Yu, W., Hsu, T., Ding, Y.-A., & Chang, M.-S. (1999) · Circulation · doi:10.1161/01.cir.100.18.1879 · Cited by 1,442
Cappato, R., Calkins, H. G., Chen, S., Davies, W. D., Iesaka, Y., Kalman, J. M., Kim, Y.-H., Klein, G. J., Packer, D. L., & Skanes, A. C. (2005) · Circulation · doi:10.1161/01.cir.0000157153.30978.67 · Cited by 1,303
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S.-A., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haïssaguerre, M., et al. (2007) · EP Europace · doi:10.1093/europace/eum120 · Cited by 1,289
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,161
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M. R., Dorian, P., Connolly, S. J., Eisenberg, M. J., Green, M. S., Kuś, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,142
Research works printed but not linked: 1
- 10.1161/circ.98.23.2574 · DOI
Cited by
Sorted by citations
Items 201–300 of 847
Kuchynka, P., Podzimková, J., Masek, M., Lambert, L., Černý, V., Danek, B. A., & Paleček, T. (2015) · BioMed Research International · doi:10.1155/2015/247865 · Cited by 35
Murakawa, Y., Nogami, A., Shoda, M., Inoue, K., Naito, S., Kumagai, K., Miyauchi, Y., Yamane, T., Morita, N., Okumura, K., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0099 · Cited by 36
“Even though the efficacy of AF ablation over multiple procedures is estimated to be 73–81% [14], the majority of patients who underwent AF ablation twice but experienced recurrence declined a third session.”
BackgroundNielsen, A. B., Skaarup, K. G., Lassen, M. C. H., Djernæs, K., Hansen, M. L., Svendsen, J. H., Johannessen, A. C., Hansen, J., Sørensen, S. K., Gislason, G., et al. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01828-2 · Cited by 39
Tang, R., Yan, X.-L., Dong, J., Kalifa, J., Long, D., Yu, R., Bai, R., Kang, J.-P., Wu, J., Sang, C., et al. (2014) · EP Europace · doi:10.1093/europace/euu013 · Cited by 36
Karataş, M. B., Durmuş, G., Zengin, A., Gökalp, M., Hayıroğlu, M. İ., Çınar, T., Gürkan, K., & Çam, N. (2022) · Medicina · doi:10.3390/medicina58121872 · Cited by 35
“Despite improvements in this technology and the better understanding of pathophysiological mechanisms, freedom from AF after a successful ablation procedure can still be as low as 57% [3].”
BackgroundSafety, Feasibility and Economic Impact of Same-Day Discharge Following Atrial Fibrillation Ablation
Reddy, S. A., Nethercott, S. L., Chattopadhyay, R. K., Heck, P. M., & Virdee, M. S. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.02.016 · Cited by 35
Cryoablation for atrial fibrillation
Andrade, J. G. (2020) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.02.004 · Cited by 35
“Multiple large observational studies and randomized controlled trials have shown that catheter ablation, which is centered on electrical isolation of triggering foci within the pulmonary veins (PVs), is superior to antiarrhythmic drug (AAD) therapy in maintaining sinus rhythm and improving AF-related symptoms and qual…”
BackgroundO’Neill, L., Hensey, M., Nolan, W., & Keane, D. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-0024-2 · Cited by 35
Ngo, L., Lee, X. W., Elwashahy, M., Arumugam, P., Yang, I. A., Denman, R. A., Haqqani, H. M., & Ranasinghe, I. (2023) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcad037 · Cited by 36
Cryoballoon Ablation for Atrial Fibrillation
Andrade, J. G., Dubuc, M., Guerra, P. G., Macle, L., Rivard, L., Roy, D., Talajic, M. R., Thibault, B., & Khairy, P. (2012) · Indian Pacing and Electrophysiology Journal · doi:10.1016/s0972-6292(16)30479-x · Cited by 34
“Unfortunately, major complications including thromboembolism, cardiac perforation, and injury to adjacent structures are not infrequently observed [2,3,7,9,10].”
BackgroundResultInfluentialCatheter ablation of atrial fibrillation as first-line therapy--a single-centre experience
Tanner, H., Makowski, K., Roten, L., Seiler, J., Schwick, N. G., Muller, C., Fuhrer, J., & Delacrétaz, E. (2011) · EP Europace · doi:10.1093/europace/eur065 · Cited by 34
Ebert, M., Stegmann, C., Kosiuk, J., Dinov, B., Richter, S., Arya, A., Müssigbrodt, A., Sommer, P., Hindricks, G., & Bollmann, A. (2017) · EP Europace · doi:10.1093/europace/eux327 · Cited by 35
Hiraya, D., Sato, A., Hoshi, T., Watabe, H., Yoshida, K., Komatsu, Y., Sekiguchi, Y., Nogami, A., Ieda, M., & Aonuma, K. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14029 · Cited by 34
“A previous meta‐analysis found that the single‐procedure success rate of PVI for all types of AF without antiarrhythmic drugs was 50% to 64%.(8) It follows that the rate of AF recurrence after successful PVI remains relatively high.”
BackgroundWinkle, R. A., Mead, R. H., Engel, G., & Patrawala, R. A. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.10.048 · Cited by 34
Bertaglia, E., Senatore, G., Michieli, L. D., Simone, A. D., Amellone, C., Ferretto, S., Rocca, V. L., Giuggia, M., Corrado, D., Zoppo, F., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.12.023 · Cited by 34
Soft Bioelectronics for Heart Monitoring
Mirzajani, H., & Kraft, M. D. (2024) · ACS Sensors · doi:10.1021/acssensors.4c00442 · Cited by 34
Zhao, L., Lyu, R., Lei, H., Lin, Q., Zhou, A., Ma, H., Wang, J., Meng, X., Shao, C., Tang, Y., et al. (2024) · Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies · doi:10.1145/3678550 · Cited by 39
Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation
Waks, J. W., & ZIMETBAUM, P. J. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416651722 · Cited by 34
Saglietto, A., Gaïta, F., Ponti, R. D., Ferrari, G. M. D., & Anselmino, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.664647 · Cited by 33
Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression
Curtis, A. B., & Shukla (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s49334 · Cited by 34
Predictors for Progression of Atrial Fibrillation in Patients Awaiting Atrial Fibrillation Ablation
Kochhäuser, S., Dechering, D. G., Trought, K., Hache, P., Haig-Carter, T., Khaykin, Y., Wulffhart, Z. A., Pantano, A. A., Tsang, B., Eckardt, L., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.031 · Cited by 32
McCarthy, P. M., Cox, J. L., Kislitsina, O. N., Kruse, J. T., Churyla, A., Malaisrie, S. C., & Mehta, C. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010210 · Cited by 31
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
Andrade, J. G., Turgeon, R. D., Macle, L., & Deyell, M. W. (2022) · European Cardiology Review · doi:10.15420/ecr.2021.38 · Cited by 33
Nührich, J. M., Steven, D., Berner, I., Rostock, T., Hoffmann, B. A., Servatius, H., Sultan, A., Lüker, J., Treszl, A., Wegscheider, K., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.06.002 · Cited by 31
Müller, P., Halbfaß, P., Szöllösi, A., Dietrich, J. W., Fochler, F., Nentwich, K., Roos, M., Krug, J., Schmitt, R. R., Mügge, A., et al. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0117-6 · Cited by 31
Pieragnoli, P., Perini, A. P., Ricciardi, G., Checchi, L., Giomi, A., Muraca, I., Mannucci, L., & Padeletti, L. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13190 · Cited by 31
“The main findings of the present study may be summarized as follows: (1) AT/AF recurrences within the blanking period after CB PVI occur in about a quarter of patients, and are associated with late recurrences at 1 year in more than 80% of cases; (2) the strategy of continuously monitoring the cardiac rhythm by an ILR…”
BackgroundMethodInfluentialCsécs, I., Yamaguchi, T., Kheirkhahan, M., Czimbalmos, C., Fochler, F., Kholmovski, E. G., Morris, A. K., Kaur, G., Vágó, H., Merkely, B. P., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.12.010 · Cited by 31
Intracardiac Echocardiography during Catheter-Based Ablation of Atrial Fibrillation
Biermann, J., Bode, C., & Asbach, S. (2012) · Cardiology Research and Practice · doi:10.1155/2012/921746 · Cited by 30
Yang, Y., Liu, Q., Wu, Z., Li, X., Xiao, Y., Tu, T., & Zhou, S. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12966 · Cited by 30
Surgical ablation for atrial fibrillation
Fragakis, N., Pantos, I., Younis, J., Hadjipavlou, M., & Katritsis, D. G. (2012) · EP Europace · doi:10.1093/europace/eus081 · Cited by 29
Padeletti, L., Curnis, A., Tondo, C., Lunati, M., Porcellini, S., Verlato, R., Sciarra, L., SENATORE, G., Catanzariti, D., Leoni, L., et al. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12975 · Cited by 29
Atrial fibrillation in the cardiometabolic patient
Sensi, F. D., Costantino, S., Limbruno, U., & Paneni, F. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05882-2 · Cited by 29
Gal, P., Aarntzen, A. E. S. M., Smit, J. J. J., Adiyaman, A., Misier, A. R. R., Delnoy, P. P. H. M., & Elvan, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.034 · Cited by 28
Al‐Khatib, S. M., Calkins, H. G., Eloff, B. C., Packer, D. L., Ellenbogen, K. A., Hammill, S. C., Natale, A., Page, R. L., Prystowsky, E. N., Jackman, W. M., et al. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.10.018 · Cited by 28
Radiofrequency Catheter Ablation For Atrial Fibrillation: Approaches And Outcomes
Kalla, M., Sanders, P., Kalman, J. M., & Lee, G. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.125 · Cited by 29
Kashyap, V., Caprio, A., Doshi, T., Jang, S.-J., Liu, C. F., Mosadegh, B., & Dunham, S. N. (2020) · Science Advances · doi:10.1126/sciadv.abc6800 · Cited by 28
Wasmer, K., BREITHARDT, G. E., & Eckardt, L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu113 · Cited by 29
Genetic ACE I/D Polymorphism and Recurrence of Atrial Fibrillation After Catheter Ablation
Ueberham, L., Bollmann, A., Shoemaker, M. B., Arya, A., Adams, V., Hindricks, G., & Husser, D. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000253 · Cited by 28
Muneretto, C., Bisleri, G., Rosati, F., Krakor, R., Giroletti, L., Bacco, L. D., Repossini, A., Moltrasio, M., Curnis, A., Tondo, C., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx162 · Cited by 28
Williams, S. E., O’Neill, L., Roney, C. H., Calvo, J. J. C. J., Metzner, A., Reißmann, B., Mukherjee, R. K., Sim, I., Whitaker, J., Wright, M. J., et al. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13990 · Cited by 26
“incorporated the vast majority of patients with paroxysmal AF which is in line with success rates of pulmonary vein isolation in this population.(29) Notably, however, even persistent AF patients with LAECS < 4 cm were noninducible after pulmonary vein isolation, suggesting that isolation of PV triggers could be succe…”
ResultComparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation
Qin, D., Leef, G. C., Alam, M. B., Rattan, R., Munir, M. B., Patel, D. R., Khattak, F. H., ADELSTEIN, E. C., Jain, S. K., & Saba, S. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.07.001 · Cited by 29
“All rights AF [7–10], and is often achieved using antiarrhythmic drugs (AAD) that alter the function of membrane channels in cardiac myocytes [11,12,7,13,14].”
BackgroundCatheter Ablation vs Lifestyle Modification With Antiarrhythmic Drugs to Treat Atrial Fibrillation
Osmancik, P. P., Roubíček, T., Havránek, Š., Chovančík, J., Bulková, V., Heřman, D., Matoulek, M., Tuka, V., Ranič, I., Hozmanová, J., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.04.042 · Cited by 33
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 34
Casciola, M., Keck, D. M., Feaster, T. K., & Blinova, K. (2022) · Physiological Reports · doi:10.14814/phy2.15493 · Cited by 27
“Major periprocedural complications were reported in 5% of patients treated using RF ablation (Calkins et al., 2009).”
BackgroundAtrial fibrillation: Stroke prevention in focus
Ferguson, C., Inglis, S. C., Newton, P. J., Middleton, S., Macdonald, P. S., & Davidson, P. M. (2013) · Australian Critical Care · doi:10.1016/j.aucc.2013.08.002 · Cited by 27
Iqbal, M., Kamarullah, W., Pranata, R., Putra, I. C. S., Karwiky, G., Achmad, C., & Kim, Y. (2024) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2024.05 · Cited by 26
Castagno, D., Donna, P. D., Olivotto, I., Frontera, A., Calò, L., Scaglione, M., Arretini, A., Anselmino, M., Giustetto, C., Ferrari, G. M. D., et al. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14880 · Cited by 26
“In patients without underlying structural heart disease RFCA can be more effective than antiarrhythmic drugs showing similar complication rates.(15,16) Although RFCA has been proved feasible also in patients with HCM, only data from small, single‐center studies mainly focusing on short‐term results are currently avail…”
BackgroundAtrio-Esophageal Fistula: A Case Series and Literature Review
Schuring, C. A., Mountjoy, L. J., Priaulx, A. B., Schneider, R. J., Smith, H. L., Wall, G. C., Kadaria, D., & Sodhi, A. (2017) · American Journal of Case Reports · doi:10.12659/ajcr.903966 · Cited by 28
Zucchelli, G., Sirico, G., Rebellato, L., Marini, M., Stabile, G., Greco, M. D., Castro, A., Ruvo, E. D., Soldati, E., Zingarini, G., et al. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-0421 · Cited by 26
“Exclusion criteria were: (1) persistent and permanent AF; (2) previous catheter ablation of AF; (3) New York Heart Association functional class >II; (4) left atrial diameter (LAd) >50 mm in the parasternal long-axis view; (5) unstable angina or acute myocardial infarction within 3 months; (6) need for or prior cardiac…”
BackgroundMethodImpact of Atrial Fibrillation Ablation on Recurrent Hospitalization
Guo, J., Nayak, H. M., Besser, S. A., Beaser, A. D., Aziz, Z. A., Broman, M., Özcan, C., Tung, R. H., & Upadhyay, G. A. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.10.015 · Cited by 26
“nuscript received July 23, 2018; revised manuscript received September of pulmonary veins and other ectopic foci has become a mainstay treatment for drug-refractory symptomatic AF (5).”
BackgroundCan we improve outcomes in AF patients by early therapy?
Kirchhof, P. F. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-72 · Cited by 26
“rate in patients with paroxysmal AF compared to patients with sustained forms of the arrhythmia [31].”
ResultKwiecinski, W., Provost, J., Dubois, R., Sacher, F., Haı̈ssaguerre, M., Legros, M., Nguyen‐Dinh, A., Dufait, R., Tanter, M., & Pernot, M. (2014) · Medical Physics · doi:10.1118/1.4896820 · Cited by 25
Wasmer, K., & Eckardt, L. (2011) · EP Europace · doi:10.1093/europace/eur172 · Cited by 25
Comparing the 2010 North American and European Atrial Fibrillation Guidelines
Gillis, A. M., & Skanes, A. C. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.009 · Cited by 25
Ablation of multi-wavelet re-entry: general principles and in silico analyses
Spector, P., de Sa, D. D. C., Tischler, E. S., Thompson, N. C., Habel, N., Stinnett-Donnelly, J. M., Benson, B. E., Bielau, P., & Bates, J. H. T. (2012) · EP Europace · doi:10.1093/europace/eus278 · Cited by 25
Kaypaklı, O., Koca, H., Şahin, D. Y., Okar, S., Karataş, F., & Koç, M. (2017) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2017.09.016 · Cited by 25
Amin, A. M., Ghaly, R., Ibrahim, A. A. A., Ali, M. A., Almaadawy, O., Elzahaby, A., Abuelazm, M. T., Abdelazeem, B., & Munir, M. B. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01782-2 · Cited by 26
Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation
Blackhouse, G., Assasi, N., Xie, F., Gaebel, K., Campbell, K., Healey, J. S., O’Reilly, D. J., & Goeree, R. A. (2013) · International Journal of Vascular Medicine · doi:10.1155/2013/262809 · Cited by 25
“The probability of AF ablation procedural complications was taken from a systematic review of RCT and non-RCT studies evaluating catheter-based AF ablation procedures [31].”
MethodGal, P., Smit, J. J. J., Adıyaman, A., Misier, A. R. R., Delnoy, P. P. H. M., & Elvan, A. (2014) · Netherlands Heart Journal · doi:10.1007/s12471-014-0624-y · Cited by 24
“Pulmonary vein isolation (PVI) has become an important treatment modality for atrial fibrillation (AF) [1, 2] although AF recurrences can occur [3].”
BackgroundMethodCohen, A. A., Dallongeville, J., Durand‐Zaleski, I., Bouée, S., & Heuzey, J. L. (2010) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2010.06.001 · Cited by 24
Kwiecinski, W., Bessière, F., Constanciel, É., N’Djin, W. A., Tanter, M., Lafon, C., & Pernot, M. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/20/7829 · Cited by 24
Assasi, N., Blackhouse, G., Xie, F. X., Gaebel, K., Robertson, D., Hopkins, R. B., Healey, J. S., Roy, D., & Goeree, R. A. (2012) · Europe PMC (PubMed Central) · Cited by 24
Krul, S. P. J., Pison, L., Meir, M. L., Driessen, A. H. G., Wilde, A. A. M., Maessen, J. G., de Mol, B. A. J. M., Crijns, H. J. G. M., & de Groot, J. R. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.02.043 · Cited by 23
“Catheter-based pulmonary vein antrum isolation (PVAI) [2] is most effective in patients with paroxysmal AF [3,4] and normally sized left”
BackgroundThree-month lower-dose flecainide after catheter ablation of atrial fibrillation
Hayashi, M., Miyauchi, Y., Iwasaki, Y., Yodogawa, K., Tsuboi, I., Uetake, S., Hayashi, H., Takahashi, K., & Shimizu, W. (2014) · EP Europace · doi:10.1093/europace/euu041 · Cited by 23
Barrio-López, M. T., Ruiz‐Canela, M., Ramos, P., Tercedor, L., Ibáñez, J. L., Ortiz, M., Goñi, L., Ibáñez-Críado, A., Ruiz, R. M., García‐Bolao, I., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.10.009 · Cited by 23
Atrial Fibrillation: The Science behind Its Defiance
Czick, M. E., Shapter, C., & Silverman, D. I. (2016) · Aging and Disease · doi:10.14336/ad.2016.0211 · Cited by 26
“For nonsurgical AF candidates, intravascular catheter ablation is increasingly utilized, and meta-analyses have shown it to be more successful against AF than antiarrhythmic drugs [226, 227].”
BackgroundMartin, A., Godiér, A., Narayanan, K., Smadja, D. M., & Marijon, É. (2018) · Circulation · doi:10.1161/circulationaha.117.033326 · Cited by 23
[Mechanism of the therapeutic action of whole mare's and camel's milk in chronic hepatitis].
Sharmanov, T. S., Zhangabylov, A. K., & Rd, Z. (1982) · PubMed · Cited by 23
Jia, S., Nivet, H., Harrison, J., Pennec, X., Camaioni, C., Jaı̈s, P., Cochet, H., & Maxime Sermesant, B. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.10.013 · Cited by 22
“LA shape to predict AF recurrence The characteristics of the studied population are consistent with the usual population of AF patients referred for catheter ablation.(20) Patient outcomes are also consistent with prior reports, with recurrence rates (15% in paroxysmal and 35% in persistent AF over a 1-year median fol…”
ResultHennings, E., Aeschbacher, S., Coslovsky, M., Paladini, R. E., Meyre, P. B., Voellmin, G., Blum, L., Kastner, P., Ziegler, A., Conen, D., et al. (2023) · EP Europace · doi:10.1093/europace/euad149 · Cited by 21
“Among the different methods of rhythm control for atrial fibrillation (AF), catheter ablation (CA) represents a safe and effective alternative to antiarrhythmic drugs for maintaining sinus rhythm.(1,2) However, AF recurs in about one-third of patients after CA, which poses a major clinical challenge.”
BackgroundAtrial fibrillation: the rate versus rhythm management controversy
Aj, C., & Savelieva, I. (2012) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2012.s03 · Cited by 22
Speziale, G., Bonifazi, R., Nasso, G., Bartolomucci, F., Caldarola, P., Fattouch, K., Martines, G., Tavazzi, L., & Chierchia, S. L. (2010) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.03.057 · Cited by 22
Biase, L. D., Perini, A. P., Mohanty, P. K., Goldenberg, A. S., Grifoni, G., Santangeli, P., Santoro, F., Sánchez, J., Horton, R., Gallinghouse, G. J., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.11.016 · Cited by 22
Left Ventricular Hypertrophy and Antiarrhythmic Drugs in Atrial Fibrillation: Impact on Mortality
Chung, R., Houghtaling, P. L., Tchou, M. J., Niebauer, M. J., Lindsay, B. D., TCHOU, P. J., & Chung, M. K. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12426 · Cited by 22
Catheter Ablation of Atrial Fibrillation
Tung, R. H., Buch, E. F., & Shivkumar, K. (2012) · Circulation · doi:10.1161/circulationaha.111.048421 · Cited by 22
Imaging before cryoablation of atrial fibrillation: is phrenic nerve palsy predictable?
Canpolat, U., Aytemir, K., zal, M. H., rolan, T. H., Yorgun, H., ahiner, L., Kaya, E. B., & Oto, A. (2013) · EP Europace · doi:10.1093/europace/eut155 · Cited by 22
Evaluating the Cost-effectiveness of Catheter Ablation of Atrial Fibrillation
Chang, A. Y., Kaiser, D. W., Ullal, A. J., Perino, A. C., Heidenreich, P. A., Turakhia, M. P., & Veterans Affairs Palo Alto Health Care System, C. (2014) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2014.3.3.177 · Cited by 22
Ma, X., Zhang, Y.-L., Hu, B., Zhu, M., Jiang, W., Wang, M., Zheng, D.-Y., & Xue, X. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.11.005 · Cited by 22
Anatomical predisposing factors of transmural thermal injury after pulmonary vein isolation
Kaneshiro, T., Matsumoto, Y., Nodera, M., Kamioka, M., Kamiyama, Y., Yoshihisa, A., Ohkawara, H., Suzuki, H., & Takeishi, Y. (2017) · EP Europace · doi:10.1093/europace/eux185 · Cited by 22
Waldo, A. L., Wilber, D. J., Marchlinski, F. E., Stevenson, W. G., AKER, B., Boo, L. M., & Jackman, W. M. (2012) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2012.03480.x · Cited by 22
Lane, D. A., Andrade, J. G., Arbelo, E., Boriani, G., Hendriks, J., Lee, S., Lip, G. Y. H., Mant, J., & Middeldorp, M. E. (2026) · The Lancet · doi:10.1016/s0140-6736(25)02166-x · Cited by 25
Jobs, A., Schwind, J., Katalinic, A., Babaev, V., Tilz, R. R., Rausch, S., Thiele, H., Eitel, I., & Eitel, C. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1321-4 · Cited by 21
Huo, Y., Holmqvist, F., Carlson, J., Gaspar, T., Hindricks, G., Piorkowski, C., Bollmann, A., & Platonov, P. G. (2014) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2014.11.011 · Cited by 21
“Over the last decade, studies of radiofrequency catheter ablation for treatment of AF reported higher efficacy rates than did studies of antiarrhythmic drug therapy [9–12].”
ResultLong-Term Benefits Following Catheter Ablation of Atrial Fibrillation
Latchamsetty, R., & Morady, F. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0298 · Cited by 21
Risom, S. S., Zwisler, A., Rasmussen, T. B., Sibilitz, K. L., Svendsen, J. H., Gluud, C. N., Hansen, J. L., Winkel, P., Thygesen, L. C., Perhonen, M. A., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002377 · Cited by 21
“RFA is an invasive treatment, intended to cure AF, and has a success rate of 77% versus 52% for antiarrhythmic medication.(15) In Denmark, around 600 RFAs are conducted annually at two heart centres.”
BackgroundNakanishi, K., Fukuda, S., Yamashita, H., Hasegawa, T., Kosaka, M., Shirai, N., Shimada, K., Yoshikawa, J., & Tanaka, A. (2017) · EP Europace · doi:10.1093/europace/euw314 · Cited by 21
Atrial Fibrillation and Risk of Dementia/Cognitive Decline.
SHAH, A. D., Merchant, F. M., & DeLurgio, D. B. (2016) · PubMed · doi:10.4022/jafib.1353 · Cited by 21
The Past, the Present, and the Future of Cardiac Arrhythmia Ablation
Andrade, J. G., Rivard, L., & Macle, L. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.07.731 · Cited by 22
Barakat, A. F., Wazni, O. M., Saliba, W. I., Yzeiraj, E., Amuthan, R., Rehman, K. A., Tarakji, K. G., Bassiouny, M., Baranowski, B. J., TCHOU, P. J., et al. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13434 · Cited by 21
Gorla, R., Dentali, F., Crippa, M., Marazzato, J., Minno, M. N. D. D., Grandi, A. M., & Ponti, R. D. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.04.006 · Cited by 20
“interrupted for OB) is comparable to or even lower than that reported in large prospective studies (58–60), administrative databases (61–64), meta-analyses (65,66), and surveys (67,68) published over the past decade on patients mainly treated with vitamin K antagonists.”
ResultFang, Y., Hou, W., Zhou, C. Y., Yin, Y., Lu, S., Duan, C., Cao, M., Li, M., Toft, E. S., & Zhang, H. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000654 · Cited by 20
Roh, S., Lee, D. I., Hwang, S. H., Lee, K., Baek, Y., Iqbal, M., Kim, D., Ahn, J., Shim, J., Choi, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72929-0 · Cited by 20
Update on the management of atrial fibrillation
Amerena, J. V., Walters, T. E., Mirzaee, S., & Kalman, J. M. (2013) · The Medical Journal of Australia · doi:10.5694/mja13.10191 · Cited by 20
Kotecha, D., & Kirchhof, P. F. (2014) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2014-110062 · Cited by 20
“4 Another study previously confirmed that catheter ablation maintains sinus rhythm better than AAD alone.(5) The clinical application of these findings is troublesome, particularly as this review combines tabular data from different types of AF, which diverge in terms of mechanism, prognosis and the response to treatm…”
BackgroundExecutive Summary of the II Brazilian Guidelines for Atrial Fibrillation
de Magalhães, L. P., Figueiredo, M. J. D. O., Cintra, F. D., Saad, E., Kuniyoshi, R. R., Filho, A. M. L., d’Ávila, A., de Paola, Â. A. V., Kalil, C., Moreira, D. A. R., et al. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160190 · Cited by 19
Predictors of Atrial Fibrillation Recurrence after Catheter Ablation.
Epicoco, G., & Sorgente, A. (2014) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1016 · Cited by 20
EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION
Sp, G., Панченко, Е. П., Станиславовна, К. Е., Laiovich, L. I., Maykov, E. B., Mironov, N. Y., & Shakhmatova, O. O. (2019) · Eurasian heart journal · doi:10.38109/2225-1685-2019-4-4-85 · Cited by 21
Mariani, M. V., Palombi, M., Jabbour, J. P., Pierucci, N., Cipollone, P., Piro, A., Chimenti, C., Miraldi, F., Vizza, C. D., & Lavalle, C. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01867-y · Cited by 19
Andrade, J. G., Bennett, R. G., Deyell, M. W., Bennett, M., Phulka, J., Hawkins, N. M., Aksu, T., Field, T. S., Aguilar, M., Khairy, P., et al. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.09.003 · Cited by 20
Degener, S., Pattberg, S. V., Feuersenger, H., Bansmann, P. M., Shin, D., Krummenauer, F., & Horlitz, M. (2011) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-010-9540-2 · Cited by 19
“The risk of major complications such as stroke, transient ischemic attacks, and pericardial tamponade is about 5% [12, 13 ].”
Background
Metadata
- Authors
- Calkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., Williams, C. J., & Sledge, I.
- Affiliations
- University of Vermont (US)
- Venue
- Circulation Arrhythmia and Electrophysiology
- Published
- 2009-08
- Volume
- 2
- Issue
- 4
- Pages
- 349-361
- ISSN
- 1941-3084 (ISSN-L)
- 1941-3149
- OpenAlex
- W2020741490
- Cited by
- 847
- References
- 128
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 42 · 2023: 33 · 2022: 38 · 2021: 48 · 2020: 35 · 2019: 37 · 2018: 43 · 2017: 54 · 2016: 62 · 2015: 63 · 2014: 72 · 2013: 69 · 2012: 74
- FWCI
- 43.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Arrhythmia and Electrophysiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, radiofrequency catheter ablation, antiarrhythmic drugs, amiodarone, dofetilide, sotalol, flecainide, propafenone, treatment efficacy, procedural complications, ablation success rate
- MeSH terms
- Anti-Arrhythmia Agents, Atrial Fibrillation, Humans, Catheter Ablation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review